We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
-2.21%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$1.25B
AUM Growth
-$44.8M
Cap. Flow
+$13.3M
Cap. Flow %
1.07%
Top 10 Hldgs %
26.31%
Holding
782
New
96
Increased
334
Reduced
256
Closed
61

Top Sells

Rank Stock Value
1
HOUS
Anywhere Real Estate
HOUS
+$2.84M
2
OWL icon
Blue Owl Capital
OWL
+$2.56M
3
AAPL icon
Apple
AAPL
+$2.4M
4
LLY icon
Eli Lilly
LLY
+$2.39M
5
COR icon
Cencora
COR
+$2.31M

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Financials 14.83%
3 Healthcare 7.65%
4 Consumer Discretionary 4.97%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADT icon
701
ADT
ADT
$5.16B
$145K 0.01%
22,016
-23,568
-52% -$177K
CRML icon
702
Critical Metals Corp
CRML
$853M
$144K 0.01%
18,104
+1,300
+8% +$15K
EVLV icon
703
Evolv Technologies
EVLV
$943M
$133K 0.01%
+22,051
New +$129K
CDZI icon
704
Cadiz
CDZI
$266M
$115K 0.01%
+23,344
New +$128K
IBRX icon
705
ImmunityBio
IBRX
$7.44B
$108K 0.01%
+14,100
New +$96.5K
CCC
706
CCC Intelligent Solutions
CCC
$3.42B
$106K 0.01%
+17,740
New +$116K
PRME icon
707
Prime Medicine
PRME
$533M
$105K 0.01%
30,070
+3,570
+13% +$13.6K
GTM
708
ZoomInfo Technologies
GTM
$861M
$104K 0.01%
17,340
+4,231
+32% +$31.1K
BLNE
709
Beeline Holdings
BLNE
$30.6M
$68.2K 0.01%
29,000
-47,925
-62% -$132K
ACVA icon
710
ACV Auctions
ACVA
$1.35B
$64.6K 0.01%
15,237
-426
-3% -$2.79K
OPK icon
711
Opko Health
OPK
$921M
$59.2K ﹤0.01%
51,905
-836
-2% -$1.03K
MPT
712
Medical Properties Trust
MPT
$2.89B
$49.4K ﹤0.01%
10,660
-2,882
-21% -$15K
NWL icon
713
Newell Brands
NWL
$2.16B
$48.3K ﹤0.01%
14,080
+2,955
+27% +$12.4K
UWMC icon
714
UWM Holdings
UWMC
$621M
$41.8K ﹤0.01%
11,545
+210
+2% +$966
ASTI icon
715
Ascent Solar Technologies
ASTI
$29M
$39.4K ﹤0.01%
+10,000
New +$55.4K
IKT icon
716
Inhibikase Therapeutics
IKT
$366M
$27.1K ﹤0.01%
+16,107
New +$28.6K
CELG.RT
717
Bristol-Myers Squibb Rights
CELG.RT
$12.7K ﹤0.01%
109,175
SKYX icon
718
SKYX Platforms
SKYX
$155M
$11.4K ﹤0.01%
+10,212
New +$21.3K
FACWW
719
Factorial Energy Inc Warrant
FACWW
$11.7M
$7.81K ﹤0.01%
+12,005
New +$9.42K
NFE icon
720
New Fortress Energy
NFE
$101M
$7.37K ﹤0.01%
+12,487
New +$14.6K
BENFW icon
721
Beneficient Warrant
BENFW
$186K
$700 ﹤0.01%
50,000
ACGL icon
722
Arch Capital
ACGL
$36.1B
-2,321
Closed -$223K
AIG icon
723
American International
AIG
$41.9B
-2,729
Closed -$233K
ALNY icon
724
Alnylam Pharmaceuticals
ALNY
$36.3B
-620
Closed -$247K
APP icon
725
Applovin
APP
$132B
-300
Closed -$202K

Similar funds

Transcend Capital Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Transcend Capital Advisors held 782 positions worth $1.25B, down 3.5% from $1.29B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors's Q1 2026 filing shows 96 new, 334 increased, 256 reduced and 61 closed positions. Its largest new stake was iShares 20+ Year Treasury Bond BuyWrite Strategy ETF: 103,300 shares worth $2.34M. The largest sale was Anywhere Real Estate, an estimated $2.84M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Transcend Capital Advisors's largest Q1 2026 buy was iShares 20+ Year Treasury Bond BuyWrite Strategy ETF: 103,300 shares worth $2.34M.
  • Transcend Capital Advisors added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2026, an estimated $5.24M increase.
  • Transcend Capital Advisors's biggest Q1 2026 reduction was Blue Owl Capital, cutting an estimated $2.56M.
  • Transcend Capital Advisors fully exited Anywhere Real Estate in Q1 2026, selling an estimated $2.84M.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $1.25B portfolio in Q1 2026.
  • Transcend Capital Advisors opened 96 new positions and closed 61 in Q1 2026.
  • Transcend Capital Advisors's portfolio value fell 3.5% quarter-over-quarter to $1.25B.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.